Abstract
It has been suggested that soy food and its components may relieve menopausal symptoms (MPS) including hot flashes, night sweats, and vaginal dryness in healthy women. However, little is known about the effect of soy food intake on MPS in women with breast cancer. We examined associations of occurrence of MPS with soy food intake in 4,842 Chinese women aged 20–75 years who had non-metastatic breast cancer and had not used hormone replacement therapy. MPS were assessed at 6 and 36 months after cancer diagnosis using a standardized questionnaire, and associations with soy food intake were evaluated in multivariate regression analyses. Daily soy food intake was assessed at 6 months postdiagnosis and over the first 36 months postdiagnosis using a validated food frequency questionnaire. The prevalence of MPS was 56% at 6 months and 63% at 36 months postdiagnosis with the hotflash being the most common MPS (~44–55%). Hot flashes occurred mainly in premenopausal breast cancer patients who were in the highest quartile of isoflavone intake at 6 months postdiagnosis (OR = 1.20, 95% CI: 0.98–1.59) compared with the lowest quartile. This association was stronger at 36 months postdiagnosis (OR = 1.59, 95% CI: 1.02–2.48). We found no significant associations for any MPS, night sweats, or vaginal dryness. Neither tamoxifen use nor BMI modified the association between MPS and isoflavone intake. There was no evidence that soy food consumption reduced MPS among breast cancer patients. High soy intake may increase the prevalence of hotflashes among premenopausal patients. Our study suggests that soy acts as an estrogen antagonist in breast cancer patients.
Similar content being viewed by others
References
Carpenter JS, Andrykowski MA, Cordova M et al (1998) Hot flashes in postmenopausal women treated for breast carcinoma: prevalence, severity, correlates, management, and relation to quality of life. Cancer 82:1682–1691
Crandall C, Petersen L, Ganz PA, Greendale GA (2004) Association of breast cancer and its therapy with menopause-related symptoms. Menopause 11:519–530
Dorjgochoo T, Gu K, Kallianpur A et al (2009) Menopausal symptoms among breast cancer patients 6 months after diagnosis: a report from the Shanghai Breast Cancer Survival Study. Menopause 16:1205–1212
Freeman EW, Sherif K (2007) Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 10:197–214
NIH State-of-the-Science Conference Statement on management of menopause-related symptoms (2005) NIH Consens State Sci Statements 22:1–38
Dietel M (2010) Hormone replacement therapy (HRT), breast cancer and tumor pathology. Maturitas 65:183–189
Cederroth CR, Nef S (2009) Soy, phytoestrogens and metabolism: a review. Mol Cell Endocrinol 304:30–42
Jacobs A, Wegewitz U, Sommerfeld C, Grossklaus R, Lampen A (2009) Efficacy of isoflavones in relieving vasomotor menopausal symptoms—a systematic review. Mol Nutr Food Res 53:1084–1097
Lethaby AE, Brown J, Marjoribanks J, Kronenberg F, Roberts H, Eden J (2007) Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database Syst Rev:CD001395
Nagata C, Takatsuka N, Kawakami N, Shimizu H (2001) Soy product intake and hot flashes in Japanese women: results from a community-based prospective study. Am J Epidemiol 153:790–793
Nelson HD, Vesco KK, Haney E et al (2006) Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 295:2057–2071
Krebs EE, Ensrud KE, MacDonald R, Wilt TJ (2004) Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 104:824–836
MacGregor CA, Canney PA, Patterson G, McDonald R, Paul J (2005) A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer. Eur J Cancer 41:708–714
Nikander E, Kilkkinen A, Metsa-Heikkila M et al (2003) A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol 101:1213–1220
Gold EB, Flatt SW, Pierce JP et al (2006) Dietary factors and vasomotor symptoms in breast cancer survivors: the WHEL Study. Menopause 13:423–433
Howell SJ, Johnston SR, Howell A (2004) The use of selective estrogen receptor modulators and selective estrogen receptor down-regulators in breast cancer. Best Pract Res Clin Endocrinol Metab 18:47–66
Barnes S (2010) The biochemistry, chemistry and physiology of the isoflavones in soybeans and their food products. Lymphatic Res Biol 8:89–98
Shu XO, Zheng Y, Cai H et al (2009) Soy food intake and breast cancer survival. JAMA 302:2437–2443
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
Department of Health and Human Services (1998) The international classification of diseases, 9th Rev. edn, ICD-9-CM. US Government Printing Office, Washington, DC
Shu XO, Yang G, Jin F et al (2004) Validity and reproducibility of the food frequency questionnaire used in the Shanghai Women’s Health Study. Eur J Clin Nutr 58:17–23
Yang Y, Wang G, Pan X (2002) Chinese Food Composition Tables 2002. Chinese Centre for Disease Control and Prevention, Beijing
WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163
Canney PA, Hatton MQ (1994) The prevalence of menopausal symptoms in patients treated for breast cancer. Clin Oncol (R Coll Radiol) 6:297–299
Ganz PA (2001) Menopause and breast cancer: symptoms, late effects, and their management. Semin Oncol 28:274–283
Gupta P, Sturdee DW, Palin SL et al (2006) Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 9:49–58
Penttinen-Damdimopoulou PE, Power KA, Hurmerinta TT, Nurmi T, van der Saag PT, Makela SI (2009) Dietary sources of lignans and isoflavones modulate responses to estradiol in estrogen reporter mice. Mol Nutr Food Res 53:996–1006
Hwang CS, Kwak HS, Lim HJ et al (2006) Isoflavone metabolites and their in vitro dual functions: they can act as an estrogenic agonist or antagonist depending on the estrogen concentration. J Steroid Biochem Mol Biol 101:246–253
Helferich WG, Andrade JE, Hoagland MS (2008) Phytoestrogens and breast cancer: a complex story. Inflammopharmacol 16:219–226
Tonetti DA, Zhang Y, Zhao H, Lim SB, Constantinou AI (2007) The effect of the phytoestrogens genistein, daidzein, and equol on the growth of tamoxifen-resistant T47D/PKC alpha. Nutr Cancer 58:222–229
Chen J, Hui E, Ip T, Thompson LU (2004) Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice. Clin Cancer Res 10:7703–7711
Chen J, Power KA, Mann J, Cheng A, Thompson LU (2007) Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Exp Biol Med (Maywood) 232:1071–1080
Messina M, Hughes C (2003) Efficacy of soyfoods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency. J Med Food 6:1–11
Umland EM (2008) Treatment strategies for reducing the burden of menopause-associated vasomotor symptoms. J Manag Care Pharm 14:14–19
Kronenberg F, Fugh-Berman A (2002) Complementary and alternative medicine for menopausal symptoms: a review of randomized, controlled trials. Ann Intern Med 137:805–813
Van Patten CL, Olivotto IA, Chambers GK et al (2002) Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin Oncol 20:1449–1455
Dorjgochoo T, Kallianpur A, Zheng Y et al (2010) Impact of menopausal symptoms on quality of life 6 months after systemic breast cancer treatment: results from the Shanghai Breast Cancer Survival Study. Breast Cancer Res Treat 119:725–735
Acknowledgments
We are grateful to the research staff of the Shanghai Breast Cancer Survival Study in Shanghai, China for implementing the study and to all of the women who participated in the SBCSS. We also thank Dr. Fan Jin for her contributions to the field operations and Bethanie Hull and Rod Jones for their technical assistance in the preparation of this manuscript. Funding for this study was provided by the U.S. Department of Defense Breast Cancer Research Program (DAMD 17-02-1-0607) and the National Cancer Institute (R01 CA118229).
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article can be found at http://dx.doi.org/10.1007/s10549-011-1356-y
Rights and permissions
About this article
Cite this article
Dorjgochoo, T., Gu, K., Zheng, Y. et al. Soy intake in association with menopausal symptoms during the first 6 and 36 months after breast cancer diagnosis. Breast Cancer Res Treat 130, 879–889 (2011). https://doi.org/10.1007/s10549-010-1096-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-010-1096-4